Company intelligence / Profile preview

Epizon Pharma, Inc.

New York City, New York, United Statesepizonpharma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Epizon Pharma, Inc. is developing novel therapies for microvascular calcification using long-active derivatives of Vitamin K2. Their lead candidate EPN‑701 (menaquinone‑7) has completed a Phase 2 clinical trial in patients with end-stage renal disease on hemodialysis to assess safety, pharmacokinetics, and biomarker effects. The company has also been granted a US patent for methods and compositions for preventing or treating tissue calcification. Clinical results have not yet been publicly posted as of early 2025.

Therapeutic areas: Metabolic DisordersNephrology
Modalities: Small molecules (specifically menaquinone-7/Vitamin K2 derivatives)
Industry: Biotech

Drug pipeline

2 assets

CVCO-701

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Initial collaboration involved former senior scientists from Merck, Pfizer, Roche, Amgen, Biogen and faculty from Harvard Medical School, Stanford University School of Medicine, Duke School of Medicine and Johns Hopkins School of Medicine

Beyond the preview

Go deeper on Epizon Pharma, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epizon Pharma, Inc..

Explore the full profile